Computational evidence
| Protein change | ||
| AlphaMissense | 0.1065 | likely benign |
|---|---|---|
| REVEL | 0.358 | indeterminate |
| SaProt | LLR -4.44 | tolerated |
| ⇒ AlphaMissense and SaProt both call this tolerated; REVEL makes no call. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 6.1 | GERP 1.7, phastCons 1 |
| Regional constraint | o/e 1.05 | unconstrained · MANE · 44 kb · p 0.26 · regional, not allelic |
| Overall | ||
| CADD | 22.5 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| East Asiangrpmax | 12.6% | 8 |
| Finnishnot grpmax-eligible | 9.14% | 11 |
| South Asian | 8.25% | 12 |
| Admixed American | 8.15% | 12 |
| African / African-American | 6.83% | 15 |
| Remaining individualsnot grpmax-eligible | 4.33% | 23 |
| European (non-Finnish) | 3.93% | 25 |
| Middle Eastern | 2.69% | 37 |
| Amishnot grpmax-eligible | 2.41% | 41 |
| Ashkenazi Jewishnot grpmax-eligible | 0.692% | 144 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- CTSC
- Protein
- p.Ile453Val
- Coding
- c.1357A>G
- MANE Select
- NM_001814
- dbSNP
- rs3888798
- Type
- single nucleotide variant
- Location
- chr11:88294041 (GRCh38)
- Gene constraint
- LOEUF 1.051 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 90.64 · 18 PDB
- Residue 453
- a UniProt-annotated variant site (in)
Disease context
Papillon-Lefevre disease — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsAlso linked: Haim-Munk syndromeperiodontitis, aggressive
For Papillon-Lefèvre syndrome (Orphanet):
- Inheritance
- Autosomal recessive
- Onset
- Childhood, Infancy, Neonatal
- Prevalence
- 1-9 / 1 000 000 (Worldwide)
Similar variants
- CTSC c.319-1G>A Pathogenic ★★ same condition
- CTSC c.757+1G>T Likely pathogenic ★★ same condition
- CTSC c.-55C>A Pathogenic ★★ same condition
- CTSC p.Arg210Ter Pathogenic ★★ same condition
- CTSC p.Arg250Ter Pathogenic/Likely pathogenic ★★ same condition
- CTSC p.Arg272His Pathogenic/Likely pathogenic ★★ ⚠ same condition
- CTSC p.Arg272Pro Pathogenic/Likely pathogenic ★★ same condition
- CTSC p.Arg339Cys Pathogenic/Likely pathogenic ★★ ⚠ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/ctsc-p-ile453val (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown